JPRN-UMIN000009725招募中2 期
A multicenter phase II trial of peri-operative chemotherapy with mFOLFOX6 for resectable liver metastases from colorectal cancer. - A multicenter phase II trial of peri-operative chemotherapy with mFOLFOX6 for resectable liver metastases from colorectal cancer.
3rd department of surgery Tokyo Medical University0 个研究点目标入组 40 人开始时间: 2013年1月15日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Serious drug hypersensitivity or a history of drug allergy 2. Peripheral neuropathy 3. Active concomitant malignancy 4. Severe infectious disease 5. Serious complications (renal failure or hepatic failure) 6. High blood pressure and diabetic and hypercalcemia that cannot be controlled 7. Symptomatic or asymptomatic but treated heart disease 8. Symptomatic or asymptomatic but treated heart disease 9. Histry of mental disturbances or cerebrovascular attack 10. Fresh hemorrhage from digestive tube, intestines tube paralysis, intestinal obstruction and peptic ulcer 11. Plerral effusion, peritoneal fluid and pericardial fluid 12. Symptomatic brain metastasis 13. Water solubility diarrhea, in case of the patient who has a colostomy, diarrhea impairs daily life activity 14. Under coutinuous steroid therapy 15. History of organ transplantation 16. Traumatic gracture of unrecovery 17. Pregnant women, possibly pregnant women, wishing to become pregnant, and nursing mothers 18. Other conditions not suitable for this study
研究者
相似试验
进行中（未招募）
1 期
Study of chemotherapy in operable patients with cancer of the stomachMedDRA version: 20.0Level: PTClassification code 10001150Term: Adenocarcinoma gastricSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)Gastric CancerEUCTR2017-004500-22-ITGRUPPO ONCOLOGICO ITALIANO DI RICERCA CLINICA (GOIRC)65
进行中（未招募）
1 期
A trial comparing chemotherapy and bevacizumab or lapatinib with chemotherapy alone for cancer of the stomach, oesophagus or the junction of the stomach and oesophagusPatients with histologically verfied lower oesophageal, Siewert Type I, II or III oesophagogastric junction or gastric adenocarcinoma.Type III or gastric tumours should be stage 1b (T1N1, T2a/bN0), II,III or stage IV (T4 N1orN2 M0). Lower oesophageal, Type I and II tumours should be stage II to stage IVa (T1N1, T2N1, T3N0-1, but not T2N0). T4 tumours are eligible if they involve the crura or invade the mediatinal pleural only.The tumour should be operableMedDRA version: 18.0Level: PTClassification code 10017758Term: Gastric cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 18.0Level: PTClassification code 10062878Term: Gastrooesophageal cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2006-000811-12-GBMedical Research Council Clinical Trials Unit1,100
进行中（未招募）
不适用
Chemotherapy following surgery or close follow up in upper tract urothelial cancerpper urinary tract transitional cell carcinomaMedDRA version: 15.0Level: PTClassification code 10044407Term: Transitional cell cancer of the renal pelvis and ureterSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2011-002577-33-GBInstitute of Cancer Research345
进行中（未招募）
不适用
A Phase II Multicentre Study of perioperative Chemotherapy for resectable Adenocarcinoma of the Gastroesophageal Junction and of the StomachEUCTR2008-007546-56-DEKlinikum der Universität München, Campus Großhadern
已完成
2 期
A multicenter phase II trial of pre-operative chemotherapy with Gemcitabine/ Cisplatin /S-1 for biliary tract cancers with lymph node metastasis diagnosed by FDG-PETbiliary tract cancersJPRN-UMIN000009831KHBO25